For last week’s practice question, we quizzed test takers on MR who was recently diagnosed with diabetes at age 13. 70% of respondents chose the best answer. We want to … Continue reading Rationale of the Week | New diabetes at 13, best next step?
In health care settings across the country, people with diabetes and providers have been asking if intermittent fasting is effective at helping with weight loss. Finally, a randomized outpatient study … Continue reading Does Intermittent Fasting Really Lead to Weight Loss?
Add basal insulin glargine to prevent Somogyi effect Make sure LS isn’t consuming carbohydrates after 10pm Ask LS to double check their CGM insertion site Increase the basal rate to … Continue reading Question of the Week | Best blood sugar fix?
For last week’s practice question, we quizzed test takers on fatty liver disease. 57% of respondents chose the best answer. We want to share this important information, so you can … Continue reading Rationale of the Week | What is true about fatty liver disease?
We have just added this novel, first in class, dual incretin hormone therapy, Tirzepatide (Mounjaro), to our printed version of our Diabetes Medication PocketCard. This new twin therapy includes not … Continue reading New Injectable – “TwinCretin” on Printed PocketCards
MR is 13 years old, and went to urgent care because they weren’t feeling well and told the Provider “I feel so tired all the time and I have to … Continue reading Question of the Week | New diabetes at 13, best next step?
Happy June We are excited to announce the FDA approval of a novel dual incretin injectable. The SURPASS clinical trials confirm this new diabetes medication not only drops A1C, but … Continue reading June eNews | New “Twincretin” Injection Improves Diabetes Outcomes
For last week’s practice question, we quizzed test takers on complications of hyperglycemia during pregnancy. 60% of respondents chose the best answer. We want to share this important information, so … Continue reading Rationale of the Week | Pregnancy Surprise with Type 1 Diabetes